SK바이오팜

326030 코스피
96,600 5,800 (-5.66%)
기준 : 05/15
  • 시가총액
    75,651억
  • 주식수
    7,831만
  • PER
    28.34배
  • PBR
    9.30배
  • ROE
    32.83%
  • 결산월
    12월

26.1Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2026/03 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 7,9027,902.5 7,0677,067.4 6,7546,754.0 6,2026,202.8 5,7795,779.9
내수 N/AN/A 11.0 11.0 11.0 11.0
수출 N/AN/A 5,1225,122.8 6,7536,753.0 6,2016,201.8 5,7785,778.9
기타 N/AN/A 7,0677,067.4 11.0 00.0 00.0
매출원가 N/AN/A 429429.0 338338.2 428428.1 416416.5
원재료 N/AN/A N/AN/A N/AN/A -164-164.1 N/AN/A
재고자산의변동 N/AN/A 248248.5 248248.5 331331.2 286286.1
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 620620.0 602602.1 589589.5 576576.4
감가상각비 N/AN/A 4747.7 4747.4 4646.8 4646.8
기타 N/AN/A -487-487.3 -559-559.8 -375-375.4 -492-492.8
매출총이익 N/AN/A 6,6386,638.4 6,4156,415.7 5,7745,774.6 5,3635,363.4
판매비와관리비 N/AN/A 4,5994,599.0 4,4324,432.6 4,2994,299.1 4,2464,246.2
급여 N/AN/A 1,0421,042.5 997997.6 1,0021,002.8 985985.7
퇴직급여 N/AN/A 1515.5 1616.7 1717.4 1717.7
복리후생비 N/AN/A 154154.7 160160.4 160160.5 156156.0
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 2323.5 2222.6 2121.6 2121.1
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 1818.2 6767.3 6565.7 6464.2
용역비 N/AN/A 534534.1 483483.9 457457.4 424424.0
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 638638.4 595595.8 511511.8 473473.6
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 1,7431,743.4 1,6571,657.7 1,6361,636.4 1,6761,676.3
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
감가상각비 N/AN/A 8383.4 7979.4 7373.4 7070.3
무형자산상각비 N/AN/A 3838.2 4747.6 5656.9 5959.7
기타 N/AN/A 306306.6 303303.0 294294.7 297297.3
영업이익 2,6802,680.3 2,0392,039.3 1,9831,983.1 1,4751,475.5 1,1171,117.1
EBITDA N/AN/A 1,6841,684.3 1,6741,674.8 1,1541,154.6 1,0431,043.6
금융손익 N/AN/A -147-147.6 -50-50.7 -121-121.6 3434.3
금융수익 N/AN/A 358358.5 503503.3 480480.3 474474.5
이자수익 N/AN/A 7070.8 7676.5 8383.2 9494.3
외환거래이익 N/AN/A 229229.3 361361.8 307307.1 335335.5
외환차익 N/AN/A 205205.8 198198.8 194194.3 233233.4
외화환산이익 N/AN/A 2323.5 162162.9 112112.7 102102.1
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A 11.3 11.3 1111.6
금융자산평가이익 N/AN/A 44.2 1111.1 99.9 1010.0
파생상품이익 N/AN/A 5454.0 5252.4 7878.7 2222.9
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 506506.1 554554.0 602602.0 440440.2
이자비용 N/AN/A 7676.9 9090.1 100100.1 109109.3
외환거래손실 N/AN/A 289289.1 356356.8 421421.6 217217.0
외환차손 N/AN/A 244244.1 247247.2 217217.8 159159.8
외화환산손실 N/AN/A 4444.9 109109.5 203203.8 5757.1
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A 3131.0 00.8 00.8 55.9
금융자산평가손실 N/AN/A 00.7 99.5 1919.8 2727.4
파생상품손실 N/AN/A 108108.3 9696.7 5959.5 8080.4
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A -39-39.8 -43-43.3 -11-11.1 22.7
기타영업외수익 N/AN/A 99.0 99.3 44.0 2222.0
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A 11.8
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A 55.9 55.9 N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 33.0 33.4 44.0 2020.1
기타영업외비용 N/AN/A 4848.8 5252.7 1515.2 1919.3
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 00.3 1515.0 1515.0 1515.0
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 00.1 00.1 00.0 00.0
무형자산처분손실 N/AN/A 11.8 N/AN/A N/AN/A 00.1
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 4646.5 3737.4 00.0 44.0
종속기업및관계기업관련손익 N/AN/A -343-343.0 -402-402.4 -382-382.1 -302-302.4
지분법손익 N/AN/A -343-343.0 -402-402.4 -382-382.1 -302-302.4
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A -343-343.0 -402-402.4 -382-382.1 -302-302.4
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 1,5081,508.8 1,4861,486.6 960960.5 851851.7
법인세비용 N/AN/A -1,023-1,023.7 -1,582-1,582.5 -1,458-1,458.1 -1,517-1,517.2
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 3,3633,363.6 2,5322,532.5 3,0693,069.2 2,4182,418.6 2,3682,368.9
지배지분 순이익 N/AN/A 2,6692,669.5 3,2043,204.7 2,5592,559.9 2,5122,512.1
비지배지분 순이익 N/AN/A -136-136.9 -135-135.5 -141-141.2 -143-143.1
기타포괄이익 N/AN/A -9-9.6 162162.7 66.8 145145.0
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A -26-26.8 5656.5 -53-53.4 8888.1
해외사업환산손익 N/AN/A 1212.7 112112.8 6666.3 6262.0
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 44.3 -6-6.6 -5-5.9 -5-5.1
총포괄이익 N/AN/A 2,5222,522.8 3,2313,231.9 2,4252,425.5 2,5142,514.0
지배지분 총포괄이익 N/AN/A 2,6672,667.6 3,3483,348.8 2,5702,570.1 2,6322,632.4
비지배지분 총포괄이익 N/AN/A -144-144.7 -116-116.9 -144-144.5 -118-118.3
주당순이익 N/AN/A 3,4083,408.7 4,0924,092.1 3,2683,268.8 3,2073,207.7
시가총액 N/AN/A 97,57897,578.3 79,40979,409.6 72,04872,048.1 77,76577,765.0
주가 N/AN/A 124,600124,600.0 101,400101,400.0 92,00092,000.0 99,30099,300.0
주가수익배수 N/AN/A 36.5536.55 24.7824.78 28.1428.14 30.9630.96
주식수(만주) N/A 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 7,831 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄